Non-Invasive Approaches for Cotinine Detection: Enhancing Accessibility in Tobacco Use Monitoring

Document Type : Review Article(s)

Authors

Department of Public Health Dentistry, Government Dental College, Raipur, Chhattisgarh, India

10.34172/ahj.1736

Abstract

Non-invasive approaches for cotinine detection have emerged as vital tools for enhancing access to tobacco use monitoring, addressing the pressing need for reliable, user-friendly methods in public health and clinical settings. This literature review explored various non-invasive testing methods, including saliva, urine, sweat patches, hair analysis, and breath analysis, highlighting their respective detection windows, accuracy, and feasibility. The review emphasizes the role of these methods in public health monitoring, particularly in identifying high-risk populations and facilitating smoking cessation programs. Furthermore, it discusses the implications of non-invasive testing for research on tobacco exposure and secondhand smoke, underscoring the importance of accurate data collection in shaping effective tobacco control policies. Despite the advantages, challenges such as sensitivity, specificity, and environmental factors affecting test results are critically examined. The review identifies areas for future research, including technological innovations and the potential for expanded use in low-resource settings. Ultimately, this review advocates integrating non-invasive cotinine detection methods into routine practice to improve health outcomes and promote informed decision-making about tobacco use.

Highlights

Neha Rani(Google Scholar)(Pubmed)

Keywords

References

  1. World Health Organization (WHO). Tobacco: Factsheet. Geneva: WHO; 2018.
  2. Akiyama Y, Arashidani K, Kawano W, Kunugita N. Urinary nicotine and its metabolites as a biomarker of exposure to environmental tobacco smoke. J UOEH 2006;28(3):245-52. doi:10.7888/juoeh.28.245
  3. Coleman T. Commentary on Taghavi et al. (2018): accurate measurement of tobacco smoke exposure and smoking behaviour matters. Addiction 2018;113(11):2097-8. doi:10.1111/add.14389
  4. Dai HD, Michaud T, Guenzel N, Morgan M, Cohen SM. Biomarker assessment of nicotine exposure among adolescent e-cigarette users: 2018-2019. Pediatrics 2024;153(4):e2023062424. doi:10.1542/peds.2023-062424
  5. Merianos AL, Jandarov RA, Mahabee-Gittens EM. Carcinogenic and tobacco smoke-derived particulate matter biomarker uptake and associated healthcare patterns among children. Pediatr Res 2023;93(1):143-53. doi:10.1038/s41390-022-02031-w
  6. Kim H, Lim Y, Lee S, Park S, Kim C, Hong C, et al. Relationship between environmental tobacco smoke and urinary cotinine levels in passive smokers at their residence. J Expo Anal Environ Epidemiol 2004;14 Suppl 1:S65-70. doi:10.1038/ sj.jea.7500360
  7. Oh S, Kim S, Sung E, Kim CH, Kang JH, Shin H, et al. The association between cotinine-measured smoking intensity and sleep quality. Tob Induc Dis 2022;20:77. doi:10.18332/ tid/152221
  8. Groppetti D, Pizzi G, Pecile A, Bronzo V, Mazzola SM. Cotinine as a sentinel of canine exposure to tobacco smoke. Animals (Basel) 2023;13(4):693. doi:10.3390/ani13040693
  9. Mazumder S, Shia W, Bendik PB, Achilihu H, Sosnoff CS, Alexander JR, et al. Nicotine exposure in the US population: total urinary nicotine biomarkers in NHANES 2015-2016. Int J Environ Res Public Health 2022;19(6):3660. doi:10.3390/ ijerph19063660
  10. Hajat C, Stein E, Ramstrom L, Shantikumar S, Polosa R. The health impact of smokeless tobacco products: a systematic review. Harm Reduct J 2021;18(1):123. doi:10.1186/s12954- 021-00557-6
  11. Hersi M, Beck A, Hamel C, Esmaeilisaraji L, Pussegoda K, Austin B, et al. Effectiveness of smoking cessation interventions among adults: an overview of systematic reviews. Syst Rev 2024;13(1):179. doi:10.1186/s13643-024-02570-9
  12. Le Foll B, Piper ME, Fowler CD, Tonstad S, Bierut L, Lu L, et al. Tobacco and nicotine use. Nat Rev Dis Primers 2022;8(1):19. doi:10.1038/s41572-022-00346-w
  13. Ebbert JO, Dale LC, Nirelli LM, Schroeder DR, Moyer TP, Hurt RD. Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users. Addict Behav 2004;29(2):349-55. doi:10.1016/j.addbeh.2003.08.046
  14. Avila-Tang E, Al-Delaimy WK, Ashley DL, Benowitz N, Bernert JT, Kim S, et al. Assessing secondhand smoke using biological markers. Tob Control 2013;22(3):164-71. doi:10.1136/ tobaccocontrol-2011-050298
  15. Raja M, Garg A, Yadav P, Jha K, Handa S. Diagnostic methods for detection of cotinine level in tobacco users: a review. J Clin Diagn Res 2016;10(3):ZE04-6. doi:10.7860/ jcdr/2016/17360.7423
  16. Lee K, Yoon T, Yang HS, Cha S, Cheon YP, Kashefi- Kheyrabadi L, et al. All-in-one platform for salivary cotinine detection integrated with a microfluidic channel and an electrochemical biosensor. Lab Chip 2020;20(2):320-31. doi:10.1039/c9lc01024f
  17. Mani V, Beduk T, Khushaim W, Ceylan AE, Timur S, Wolfbeis OS, et al. Electrochemical sensors targeting salivary biomarkers: a comprehensive review. Trends Analyt Chem 2021;135:116164. doi:10.1016/j.trac.2020.116164
  18. Verma VK, Verma S. Machine learning applications in healthcare sector: an overview. Mater Today Proc 2022;57(Pt 5):2144-7. doi:10.1016/j.matpr.2021.12.101
  19. Kot-Wasik A, Zabiegała B, Urbanowicz M, Dominiak E, Wasik A, Namieśnik J. Advances in passive sampling in environmental studies. Anal Chim Acta 2007;602(2):141-63. doi:10.1016/j.aca.2007.09.013
  20. Foddai SG, Radin M, Barinotti A, Cecchi I, Rubini E, Arbrile M, et al. New frontiers in autoimmune diagnostics: a systematic review on saliva testing. Int J Environ Res Public Health 2023;20(10):5782. doi:10.3390/ijerph20105782
  21. Jung C, Kim M. Direct use of a saliva-collected cotton swab in lateral flow immunoassay for the detection of cotinine. Biosensors (Basel) 2022;12(4):214. doi:10.3390/ bios12040214
  22. Jain R, Ghosh S, Saifi N. An efficient method for simultaneous detection of pheniramine, pentazocine and cotinine in urine by gas chromatography in de-addiction program. Addict Health 2022;14(2):96-104. doi:10.22122/ahj.2022.196722.1179
  23. Purushothama J, Badiger S, Kumar N, Baikunje N, D’souza N, D’Mello M, et al. Validity assessment of self-reported smoking status to detection of urine cotinine levels among patients with tuberculosis undergoing tobacco cessation treatment. Biomedicine 2022;42(2):371-6. doi:10.51248/.v42i2.1412
  24. Bartolomé M, Gallego-Picó A, Huetos O, Castaño A. High-performance liquid chromatography with diode-array detection cotinine method adapted for the assessment of tobacco smoke exposure. J Sep Sci 2014;37(12):1404-10. doi:10.1002/jssc.201301259
  25. Krokos A, Orfanidis A, Mastrogianni O, Mitsa F, Avgeri M, Eboriadou M, et al. Gas chromatography-mass spectrometry determination of nicotine and cotinine in urine: a study of the effect of passive smoking. Rapid Commun Mass Spectrom 2024;38(18):e9864. doi:10.1002/rcm.9864
  26. Terzapulo X, Kassenova A, Bukasov R. Immunoassays: analytical and clinical performance, challenges, and perspectives of SERS detection in comparison with fluorescent spectroscopic detection. Int J Mol Sci 2024;25(4):2080. doi:10.3390/ijms25042080
  27. Gluck L. A patch test for chloride in sweat as a simple screening method for detecting cystic fibrosis of the pancreas; preliminary report. Pediatrics 1959;23(4):731-7.
  28. Gambelunghe C, Fucci N, Aroni K, Bacci M, Marcelli A, Rossi R. Cannabis use surveillance by sweat analysis. Ther Drug Monit 2016;38(5):634-9. doi:10.1097/ftd.0000000000000327
  29. Huestis MA, Scheidweiler KB, Saito T, Fortner N, Abraham T, Gustafson RA, et al. Excretion of Δ9-tetrahydrocannabinol in sweat. Forensic Sci Int 2008;174(2-3):173-7. doi:10.1016/j. forsciint.2007.04.002
  30. Kintz P, Tracqui A, Mangin P, Edel Y. Sweat testing in opioid  users with a sweat patch. J Anal Toxicol 1996;20(6):393-7. doi:10.1093/jat/20.6.393 
  31. Phillips EL, Little RE, Hillman RS, Labbe RF, Campbell C. A field test of the sweat patch. Alcohol Clin Exp Res 1984;8(2):233-7. doi:10.1111/j.1530-0277.1984.tb05846.x 
  32. Saff RR, Waldron JL. The safety and accuracy of drug patch testing in delayed hypersensitivity reactions. Curr Dermatol Rep 2023;12(4):260-8. doi:10.1007/s13671-023-00405-9 
  33. Liberty HJ, Johnson BD, Fortner N. Detecting cocaine use through sweat testing: multilevel modeling of sweat patch length-of-wear data. J Anal Toxicol 2004;28(8):667-73. doi:10.1093/jat/28.8.667 
  34. Servidoni MF, Gomez CC, Marson FA, Toro A, de Oliveira Ribeiro MÂ, Ribeiro JD, et al. Sweat test and cystic fibrosis: overview of test performance at public and private centers in the state of São Paulo, Brazil. J Bras Pneumol 2017;43(2):121- 8. doi:10.1590/s1806-37562016000000076 
  35. Zhao FJ, Bonmarin M, Chen ZC, Larson M, Fay D, Runnoe D, et al. Ultra-simple wearable local sweat volume monitoring patch based on swellable hydrogels. Lab Chip 2020;20(1):168- 74. doi:10.1039/c9lc00911f 
  36. Antunes MV, da Silva CF, Finger MA, Moore C, Linden R. Correlation analysis between cotinine hair concentrations from active smokers and nicotine intake and dependence. Ther Drug Monit 2015;37(3):405-7. doi:10.1097/ ftd.0000000000000140 
  37. Eliopoulos C, Klein J, Koren G. Validation of self-reported smoking by analysis of hair for nicotine and cotinine. Ther Drug Monit 1996;18(5):532-6. doi:10.1097/00007691- 199610000-00002 
  38. Tualeka AR, Jalaludin J, Sopian NA, Aziz MY, Rahmawati P, Ahsan A, et al. The relationship between cotinine levels in the blood with glutathione, and malondialdehyde levels of smokers: a systematic review and meta-analysis. F1000Res 2023;12:1466. doi:10.12688/f1000research.134993.1 
  39. Kataoka H, Kaji S, Moai M. Risk assessment of passive smoking based on analysis of hair nicotine and cotinine as exposure biomarkers by in-tube solid-phase microextraction coupled on-line to LC-MS/MS. Molecules 2021;26(23):7356. doi:10.3390/molecules26237356 
  40. Belhadj-Tahar H, Brousse F, Malonga G, Morais S, Sadeg N. Tin hair analysis in poly symptomatic patients with Essure® implant. World J Biol Pharm Res 2023;5(1):28-35. doi:10.53346/wjbpr.2023.5.1.0065 
  41. Gili A, Bacci M, Aroni K, Nicoletti A, Gambelunghe A, Mercurio I, et al. Changes in drug use patterns during the COVID-19 pandemic in Italy: monitoring a vulnerable group by hair analysis. Int J Environ Res Public Health 2021;18(4):1967. doi:10.3390/ijerph18041967 
  42. Wang R, Hall JM, Salloum RG, Kates F, Cogle CR, Bruijnzeel AW, et al. Prevalence of underreported nicotine exposure among US nonsmoking adults: a comparison of self-reported exposure and serum cotinine levels from NHANES 2013- 2020. Nicotine Tob Res 2024;26(3):298-306. doi:10.1093/ ntr/ntad165 
  43. Oldham MJ, Bailey PC, Castro N, Lang Q, Salehi A, Rostami AA. Prediction of potential passive exposure from commercial electronic nicotine delivery systems using exhaled breath analysis and computational fluid dynamic techniques. J Breath Res 2021;15(4):046006. doi:10.1088/1752-7163/ac2884 
  44. Paulo BF, Junior LF, Zauli DA. B-205 A simple method for opioids, synthetic opioids and PCP detection in hair samples by LC-MS/MS. Clin Chem 2023;69(Suppl 1):hvad097.534. doi:10.1093/clinchem/hvad097.534 
  45. Ghosh N, Verma S. Technological advancements in glucose monitoring and artificial pancreas systems for shaping diabetes care. Curr Med Res Opin 2024;40(12):2095-107. doi:10.1080 /03007995.2024.2422005 
  46. Nyiramana Mukamurera P. Advances in non-invasive glucose monitoring: challenges, technologies, and future prospects. Res Output J Public Health Med 2024;3(3):1-5. doi:10.59298/ ROJPHM/2024/3315 
  47. Shukla A. Laser-based ultrasonics for non-destructive material testing: a practical guide. i-manager’s Journal on Material Science 2023;11(3):20-5. doi:10.26634/jms.11.3.20522 
  48. Abdallah IA, Hammell DC, Stinchcomb AL, Hassan HE. A fully validated LC-MS/MS method for simultaneous determination of nicotine and its metabolite cotinine in human serum and its application to a pharmacokinetic study after using nicotine transdermal delivery systems with standard heat application in adult smokers. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1020:67-77. doi:10.1016/j.jchromb.2016.03.020 
  49. Kim I, Huestis MA. A validated method for the determination of nicotine, cotinine, trans-3’-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. J Mass Spectrom 2006;41(6):815-821. doi:10.1002/jms.1039 
  50. Kaisar MA, Kallem RR, Sajja RK, Sifat AE, Cucullo L. A convenient UHPLC-MS/MS method for routine monitoring of plasma and brain levels of nicotine and cotinine as a tool to validate newly developed preclinical smoking model in mouse. BMC Neurosci 2017;18(1):71. doi:10.1186/s12868- 017-0389-5
Addiction & Health
Volume 18
Pages 1-8

Files

Share

How to cite

Statistics